Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial

Rolf A. Stahel(University Hospital of Zurich), Oliver Riesterer(University Hospital of Zurich), Alexandros Xyrafas(Swiss Group For Clinical Cancer Research), Isabelle Opitz(University Hospital of Zurich), Michael Beyeler(Swiss Group For Clinical Cancer Research), Adrian F. Ochsenbein(University Hospital of Bern), Martin Früh(University of St.Gallen), Richard Cathomas(Kantonsspital Graubünden), Kristiaan Nackaerts(KU Leuven), Solange Peters(University Hospital of Lausanne), Christoph Mamot(Kantonsspital Aarau), Alfred Zippelius(University Hospital of Basel), Carlo Mordasini, Clemens B. Caspar(Kantonsspital Baden), Katrin Eckhardt(Swiss Group For Clinical Cancer Research), Ralph A. Schmid(University Hospital of Bern), Daniel M. Aebersold(University Hospital of Bern), Oliver Gautschi(University Hospital of Bern), W. Nagel(University of St.Gallen), Michael Töpfer(University of St.Gallen), J. Krayenbuehl(University Hospital of Zurich), Karin Ribi(International Breast Cancer Study Group), llja F Ciernik(Städtisches Klinikum Dessau), Walter Weder(University Hospital of Zurich)
The Lancet Oncology
November 4, 2015
10.1016/s1470-2045(15)00208-9
Cited by 200

Abstract

Related Papers

Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma
Nicholas J. Vogelzang, James J. Rusthoven, James T. Symanowski et al.|Journal of Clinical Oncology|2003|3.1k
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients
David J. Sugarbaker, Raja M. Flores, Michael T. Jaklitsch et al.|Journal of Thoracic and Cardiovascular Surgery|1999|985
Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study
Tom Treasure, Loı̈c Lang-Lazdunski, David Waller et al.|The Lancet Oncology|2011|710
A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma
Valerie W. Rusch, Kenneth E. Rosenzweig, Ennapadam Venkatraman et al.|Journal of Thoracic and Cardiovascular Surgery|2001|493
Multicenter Phase II Trial of Neoadjuvant Pemetrexed Plus Cisplatin Followed by Extrapleural Pneumonectomy and Radiation for Malignant Pleural Mesothelioma
Lee M. Krug, Harvey I. Pass, Valerie W. Rusch et al.|Journal of Clinical Oncology|2009|463